AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04712929 — intervention group
Intervention type: OTHER
Intervention: Fluconazole
Description: ( Tab Fluconazole 100 mg as a mouthwash ( tablet dissolved in 10 ml of drinking water and used as a rinse for 2 minute and swallowed) once a day for 14 days WHO criteria 5As and 5Rs for tobacco cessation
Study NCT03155594 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Freestyle Libre
Description: Continuous glucose monitoring patch
Study NCT01731652 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TMX-101
Study NCT03716349 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Pulp vitality testing
Description: each tooth will be tested to determine if the pulp of the tooth responds to cold
Study NCT03716349 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Pulp vitality testing
Description: each tooth will be tested to determine if the pulp of the tooth responds to cold
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Photos
Description: Photos of teeth (Photos will be taken with a DSLR camera settings will be determined with optimal settings) and captured periodically throughout the study. Photographs will be made of the cavity preparation. Photographs will be made post-operatively
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Photos
Description: Photos of teeth (Photos will be taken with a DSLR camera settings will be determined with optimal settings) and captured periodically throughout the study. Photographs will be made of the cavity preparation. Photographs will be made post-operatively
Study NCT03716349 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: local and/or topical anesthetic
Description: Local and/or topical anesthetic will be applied as necessary to the teeth or gingiva
Study NCT03716349 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: local and/or topical anesthetic
Description: Local and/or topical anesthetic will be applied as necessary to the teeth or gingiva
Study NCT03716349 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rubber dam
Description: The area will be isolated with rubber dam isolation
Study NCT03716349 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: rubber dam
Description: The area will be isolated with rubber dam isolation
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: tooth surface cleaned
Description: The tooth surface will be cleaned with flour of pumice on a prophy cup only, cavity preparation will be performed as usual for caries removal.
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: tooth surface cleaned
Description: The tooth surface will be cleaned with flour of pumice on a prophy cup only, cavity preparation will be performed as usual for caries removal.
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: enamel margins
Description: Enamel margins will be beveled with a long flame diamond bur (8863.314.012 Komet) at 45 degrees to the external tooth surface to achieve the desired bevel length. Along with the use of the diamond bur, infinite invisible margins will be created by contouring and smoothing with a dark orange Sof-LexTM extra-thin contouring and polishing disc (3M).
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: enamel margins
Description: Enamel margins will be beveled with a long flame diamond bur (8863.314.012 Komet) at 45 degrees to the external tooth surface to achieve the desired bevel length. Along with the use of the diamond bur, infinite invisible margins will be created by contouring and smoothing with a dark orange Sof-LexTM extra-thin contouring and polishing disc (3M).
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adhesive Systems
Description: Adhesive systems will be applied according to manufacturer's instructions and selective etching of the enamel will be performed. The dental composite will be incrementally placed using a two- layer or one-layer technique based on the cavity size and light-cured (detailed adhesive instruction sheet will be chairside for reference)
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Adhesive Systems
Description: Adhesive systems will be applied according to manufacturer's instructions and selective etching of the enamel will be performed. The dental composite will be incrementally placed using a two- layer or one-layer technique based on the cavity size and light-cured (detailed adhesive instruction sheet will be chairside for reference)
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: cavity preparation
Description: The technique to be used will be determined by the size of the final cavity preparation. For small preparations a one-layer technique will be used. No backing material is necessary for the Tokuyama system, Filtek Supreme Ultra will be determined by manufacturer's wheel. A two-layer technique will be used for a large cavity preparation. Large cavity preparation is defined as being 4mm in length or more and/or at least 2mm in depth.
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cavity preparation
Description: The technique to be used will be determined by the size of the final cavity preparation. For small preparations a one-layer technique will be used. No backing material is necessary for the Tokuyama system, Filtek Supreme Ultra will be determined by manufacturer's wheel. A two-layer technique will be used for a large cavity preparation. Large cavity preparation is defined as being 4mm in length or more and/or at least 2mm in depth.
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Shade selection using Easy Shade 5
Description: A1 (shade determined by Easy Shade 5), ECM-001/Backing material, A1E/A2D (shade will be selected by shade wheel) A4 (shade determined by Easy shade5), ECM-001/Backing material, A3E/A6D (shade will be selected by shade wheel
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Shade selection using Easy Shade 5
Description: A1 (shade determined by Easy Shade 5), ECM-001/Backing material, A1E/A2D (shade will be selected by shade wheel) A4 (shade determined by Easy shade5), ECM-001/Backing material, A3E/A6D (shade will be selected by shade wheel
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Light Curing
Description: A Valo Grand curing unit (Ultradent) with an exitant irradiance with no less than 500 and no greater than 1500 mW/cm2 as measured with MARC Light Collector will be used in standard mode to deliver the required radiant exposure J/cm2 for adhesive and dental composite increments.
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Light Curing
Description: A Valo Grand curing unit (Ultradent) with an exitant irradiance with no less than 500 and no greater than 1500 mW/cm2 as measured with MARC Light Collector will be used in standard mode to deliver the required radiant exposure J/cm2 for adhesive and dental composite increments.
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Contoured and polished
Description: The restoration will be contoured and polished with - Long flame diamond bur (8863.314.012 Komet), Sof-Lex Medium (orange) Contouring and Polishing Discs (3M), Green Jiffy cup pre-polisher (Ultradent Products, Inc.), Blue and grey silicone points composite polisher gloss plus finisher (Kerr Hawe)
Study NCT03716349 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Contoured and polished
Description: The restoration will be contoured and polished with - Long flame diamond bur (8863.314.012 Komet), Sof-Lex Medium (orange) Contouring and Polishing Discs (3M), Green Jiffy cup pre-polisher (Ultradent Products, Inc.), Blue and grey silicone points composite polisher gloss plus finisher (Kerr Hawe)
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Consent
Description: The consent form will be signed, copy will be provided to the patient
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Consent
Description: The consent form will be signed, copy will be provided to the patient
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Questionnaire
Description: The health questionnaire will be completed at initial visit and updated at each follow-up visit
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Health Questionnaire
Description: The health questionnaire will be completed at initial visit and updated at each follow-up visit
Study NCT03716349 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: xray
Description: When necessary a radiograph (xray) will be obtained
Study NCT03716349 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: xray
Description: When necessary a radiograph (xray) will be obtained
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Release of medical information signed
Description: The release of medical information form will be signed
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Release of medical information signed
Description: The release of medical information form will be signed
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Oral Exam
Description: An Oral Exam will be completed
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oral Exam
Description: An Oral Exam will be completed
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Teeth Assessment
Description: The teeth assessment by subject will be completed using the Visual Analog Scale (VAS) and Verbal Rating Scale (VRS) at the follow-up visits 1 month after restoration, 1 year, 2 years and 3 years post restoration.
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Teeth Assessment
Description: The teeth assessment by subject will be completed using the Visual Analog Scale (VAS) and Verbal Rating Scale (VRS) at the follow-up visits 1 month after restoration, 1 year, 2 years and 3 years post restoration.
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Clinical Assessment
Description: A clinical assessment will be completed by the evaluators
Study NCT03716349 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Clinical Assessment
Description: A clinical assessment will be completed by the evaluators
Study NCT03716349 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tokuyama Universal Bond
Description: Tokuyama Universal Bond (TUB) single component self-etching 1-step adhesive system with Tokyuama supra-nanofilled dental composite (ECM) (Tokuyama Dental Corp., Japan)
Study NCT03716349 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: ScotchBond
Description: Scotch Bond Universal one-step adhesive system with Filtek Supreme Ultra™, nanofilled dental composite (3M)
Study NCT03961087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Coenzyme Q10
Description: Coenzyme Q10 will be given twice
Study NCT03961087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: MECLOFENOXATE
Description: MECLOFENOXATE will be given as 500 mg once daily.
Study NCT04442230 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NasoVAX
Description: NasoVAX consists of replication-deficient adenovirus vectors in suspension
Study NCT04442230 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Normal saline
Study NCT01120496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline
Description: Moderately to severely ill infants with bronchiolitis were randomized to receive 4 mL solution containing either 3% hypertonic saline or normal saline
Study NCT01120496 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: normal saline
Description: Moderately to severely ill infants with bronchiolitis were randomized to receive 4 mL solution containing either 3% hypertonic saline or normal saline
Study NCT03755648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treadmill training
Description: The motorized treadmill treatment parameters considered will be 50 Hertz, 10 Ampere and 220 Volts. The speed of treadmill will be controlled with a single finger tip allowing an individual to exercise in safe environment with sufficient space.The treadmill training will be provided by giving instructions first and then warm up will be given for 5 minutes prior to the training. The children will be upright with the feet flat on treadmill platform. The height of handrails will be adjustable according to every child thus keeping their gaze forward. The training will be ended at cool down period of 5 minutes.The treatment session will be thirty minutes for each group, six times a week for three months.
Study NCT03755648 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: traditional physical therapy
Description: Traditional therapy includes hot pack for 15 minutes and stretching for 20 minutes
Study NCT03755648 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Delorme resistance exercise
Description: Delorme Resistance Training was also initiated with 5 minute warm up period. It was started with 10 Repetition Maximum and was gradually increased. The treatment session was thirty minutes for each group, six times a week for three months.
Study NCT03105570 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Areola Sparing Mastectomy
Description: A small circular incision would be made to separate nipple from breast and an additional incision directly extended from nipple or located at other part of breast such as infra-mammary fold and subaxillary area would be made to remove the total mammary parenchyma. Routine implant based or flap base reconstruction would be performed subsequentially. Nipple reconstruction is optional.
Study NCT02037737 — intervention group
Intervention type: DRUG
Intervention: Abatacept
Study NCT04161833 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: OPERA
Description: All patients were required to take an OPERA® capsule (dietary supplement where α-lipoic acid, Boswellia Serrata, methylsulfonylmethane and bromelain are combined in a single capsule) once daily,from enrollment up to sixth months.
Study NCT01797900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: induction: Cisplatin: 80mg/m2, d1 and d22 concurrent: Cisplatin: 100mg/m2, d1, 22, 43 adjuvant: cisplatin: 75mg/m2, d1, d22, d43,d64
Study NCT01797900 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: induction: Cisplatin: 80mg/m2, d1 and d22 concurrent: Cisplatin: 100mg/m2, d1, 22, 43 adjuvant: cisplatin: 75mg/m2, d1, d22, d43,d64
Study NCT01797900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: induction: paclitaxel 175mg/m2 d1,d22 adjuvant: paclitaxel 175mg/m2 d1,d22, d43,d64
Study NCT01797900 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: induction: paclitaxel 175mg/m2 d1,d22 adjuvant: paclitaxel 175mg/m2 d1,d22, d43,d64
Study NCT01797900 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT
Description: 69.96Gy-73.43Gy to gross tumor volume, 60Gy to high-risk clinincal target volume, 50Gy to lower risk clincial target volume
Study NCT01797900 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: IMRT
Description: 69.96Gy-73.43Gy to gross tumor volume, 60Gy to high-risk clinincal target volume, 50Gy to lower risk clincial target volume
Study NCT04232579 — intervention group
Intervention type: OTHER
Intervention: Therapeutic strategy
Description: Therapeutic strategy compatible with the guidelines and development of predictive biomarkers of the response to treatment.
Study NCT04072458 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: L-Bcl-2 antisense oligonucleotide
Description: There will be 2 planned dose levels, 20, and 40 mg/m\^2. Successive cohorts of eligible patients with will be treated with BP1002. BP1002 is given as an intravenous infusion, twice weekly, as 8 doses per 28-day cycle. Cycles may be repeated every 4 weeks.
Study NCT02798536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LMB-100
Description: Administered intravenous (IV) on days 1, 3 and 5 of a 21 day cycle for up to 4 cycles (Arms A1 and A2) or 2 cycles (Arms B1 and B2)
Study NCT02798536 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel
Description: Arms B1 and B2 only. Administered intravenous (IV) on days 1 and 8 of each 21 day cycle for up to 6 cycles
Study NCT02791490 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral tablet, once daily at approximately the same time each day
Study NCT02791490 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Metformin IR
Description: All participants will take Met-IR as background medication. Initially, they will take 1 x 500 mg tablet Met-IR b.i.d. (1000 mg/day). After randomization, all participants will be titrated to 2 x 500 mg tablets of Met-IR b.i.d. (2000 mg/day).
Study NCT01119170 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Starter formula
Description: standard starter formula given from birth to 6 months of age
Study NCT01119170 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: starter formula with D-lactate producing probiotics
Description: starter formula containing probiotics given from birth to 6 months of age
Study NCT01679210 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention
Description: Stage-matched physical activity and diet intervention materials and health education.
Study NCT04234711 — intervention group
Intervention type: PROCEDURE
Intervention: Surgical strategy
Description: To compare the efficacy between conventional repair and sutureless technique for total anomalous pulmonary venous connection
Study NCT01895322 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OPC-41061
Study NCT01121393 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Gemcitabine+Cisplatin
Description: Gemcitabine d1,8, Cisplatin d1, 21 days as a course, up to 6 courses.
Study NCT01121393 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIBW 2992
Description: starting dose is 40 mg, in the event of no or minimal drug-related adverse events after one course, the dose will be increased to 50mg. in the event of certain drug related Adverse Event (AE), dose reduction will be increments of 10 mg, with the lowest dose being 20mg.
Study NCT04523506 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Botulinum toxin(Botox)
Description: This study will evaluate the use of botulinum toxin for reduced oral aperture in scleroderma patients. Botox is a neurotoxin that functions as a paralytic by preventing the release of acetylcholine to inhibit muscle contracture and decrease fibrosis by decreasing differentiation of fibroblasts to myofibroblasts, decreasing expression of collagen, and increasing expression of matrix metalloproteinase.
Study NCT00731250 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SB-705498
Description: Subjects will be administered a single dose of 400 mg SB-705498
Study NCT00731250 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Subjects will be administered SB-705498 matching placebo tablets
Study NCT00731250 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Caspaicin
Description: Subjects will be challenged with 0.5 µg, 5.0 µg and 50 µg intranasal dose
Study NCT01965262 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hema-copolymer Lens
Description: contact lens
Study NCT01965262 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: etafilcon A Lens
Description: contact lens
Study NCT04499872 — intervention group
Intervention type: OTHER
Intervention: Advance Care Plan with Trajectory Touchpoint Technique
Description: Advance Care Plan with Trajectory Touchpoint Technique
Study NCT03420950 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Rapid sequence intubation: sedative first
Description: Sedative first
Study NCT03420950 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Rapid sequence intubation: paralytic first
Description: Paralytic first
Study NCT02452580 — intervention group
Intervention type: OTHER
Intervention: Family Centered Care
Description: Neonatal intensive care toward premature infants and their parents in a unit physically and culturally optimized for parent-infant interaction 24 hours a day 7 days a week from birth to discharge.
Study NCT01272700 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: volume control
Description: Volume controlled ventilation of tidal volume 10 ml/kg
Study NCT01272700 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pressure control
Description: Pressure controlled ventilation for peak airway pressure to deliver tidal volume 10 ml/kg.
Study NCT02302898 — intervention group
Intervention type: BEHAVIORAL
Intervention: Eating Behavior Evaluation
Description: Scores will be measured on binge eating behaviors and an increased craving for sweets.
Study NCT02302898 — intervention group
Intervention type: OTHER
Intervention: Measurement of Functional gastric volume
Description: The functional gastric volume is the amount of food or liquid that can be consumed to a feeling of comfortably full in one meal.
Study NCT02302898 — intervention group
Intervention type: OTHER
Intervention: Measurement of gastric pouch and GJ size
Description: Anatomical dimensions of the gastric pouch and GJ will be determined by using an articulated measuring tool during upper GI tract endoscopy.
Study NCT01544946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 88% sucrose po
Description: 88% sucrose solution (Syrup B.P.)